Worldwide leadership.
World Class DNA Paterity Tests.
IDENTIGENE's Management Team
The IDENTIGENE management team consists of experienced professionals whose leadership impacts the global DNA testing industry and assures that each customer receives accurate results and exceptional service. Dedicated to excellence, IDENTIGENE provides the most commercially reliable DNA test results for Questions Only DNA can Answer.™
Douglas
Fogg
Chief Operating Officer
Doug Fogg is chief operating officer of the Sorenson Genomics family of companies: Sorenson Genomics, Sorenson Forensics and IDENTIGENE. Since he assumed this role in 2001, Mr. Fogg has been directing the operations of Sorenson Genomics, including its effort to define new market segments, to develop new products and services for domestic and international direct-to-consumer sales, and to establish national and international distribution networks for its laboratory services.
Mr. Fogg came to Sorenson Genomics with extensive business experience with a variety of international manufacturing companies, where he developed expertise in international marketing and OEM sales; product development; organizational development; operations management; and P&L responsibility. Prior to Sorenson Genomics, he served nine years as President and CEO of OTSCON Inc., a Japanese OEM manufacturer of automotive parts for Toyota, Honda, Nissan, Subaru and Isuzu. Mr. Fogg holds a Masters of International Business Studies (MIBS) with emphasis in international financial management and Japanese from the University of South Carolina, and a BA in International Relations from Brigham Young University.
C.
Lars Mouritsen
Chief Scientific Officer
C. Lars Mouritsen is the chief scientific officer for Sorenson Genomics, a pioneering laboratory whose mission is to provide global leadership in quality genetic testing services for the purpose of verifying human identity and relatedness. In this capacity, he directs all technical aspects of the laboratory and oversees research & development within the organization.
Mr. Mouritsen has extensive experience overseeing the development, validation and implementation of laboratory testing methods using genetics, including methods and technologies pertaining to diagnostics and human identity. He also has significant experience in molecular sequencing, a highly specialized form of genetics that enables scientists to study DNA one molecule at a time.
In the aftermath of the 26 December 2004 tsunami in Thailand, Mr. Mouritsen led his highly trained staff of forensic scientists, doctors and laboratory specialists in the utilization of effective, comprehensive methods for testing and identifying victims of this recent mass disaster. Sorenson Genomics was one of the few US organizations involved in the genetic identification and testing of tsunami victims. Using the latest genetic testing methods, the team at Sorenson Genomics was able to extract and analyze DNA from some of the most difficult cases related to the tsunami. Mr. Mouritsen has also actively assisted Thailand's Central Institute of Forensic Science (CIFS, the equivalent of CSI in the US) in establishing programs and protocols for identifying missing persons.
Mr. Mouritsen holds a BS in genetics from the University of Utah. He has been certified as a Specialist in Immunology by the American Society for Clinical Pathologists, and is certified as a Laboratory Specialist in Molecular Biology by the National Certification Agency. He has over 12 years experience in molecular pathology, diagnostics, population genetics, laboratory automation and DNA extraction methods.
Mr. Mouritsen has published numerous research articles and studies in academic journals and trade publications, and is a frequent invited speaker and presenter at scientific and genealogical conferences.
Anthony
Carter, Ph.D.
Laboratory Director
Dr. Anthony Carter assumes the technical directorship for ancestry, relationship and life sciences genetic testing at Sorenson Genomics and IDENTIGENE. He has the responsibility of reviewing all legal and non-legal casework and can provide testimony as a court-qualified expert witness. Dr. Carter plays a lead role in the creation and oversight of laboratory policies, processes and procedures, as well as the research and development and validation of new/novel genetic testing systems and methodologies for all relationship, ancestry and life sciences testing processes.
Dr. Carter received a B.S. in Management Information Systems from Louisiana Tech University in 1997 and a Ph.D. in Biological Sciences from Louisiana State University in 2005. His research focus was on typing large subfamilies of Alu retrotransposable genetic elements in the human genome, which resulted in the recovery of many markers that are useful for the inference of human geographic origins and human identity testing. Dr. Carter's previous position was as an Assistant Director at Reliagene Technologies, Inc. in New Orleans, LA, where his responsibilities included the research and development of novel identity and total human and Y quantitation systems as well as monitoring the daily operations of the paternity testing laboratory. He is an assessor for the AABB and has over eight years of research experience in human molecular genetics.
J.
Kevin Day, Ph.D.
Director of Laboratory Operations
Dr. J. Kevin Day assumed the role of Director of Laboratory Operations at Sorenson Genomics in January of 2008. He came to Sorenson Genomics three years ago as Manager of Laboratory Operations. In that role Dr. Day focused on increasing laboratory throughput capacity and improving overall efficiency of operations. In addition to directing laboratory operations, quality control, safety, and supply chain management, his current efforts are focused on implementing, refining, and improving laboratory processes associated with LEAN/Six Sigma manufacturing practices in a high throughput laboratory setting.
Before coming to Sorenson Genomics, Dr. Day was a project manager for Epigenomics, Inc., a Berlin, Germany-based biotech company devoted to development of cancer specific markers. While working out of their Seattle office he pioneered discovery and development of a series of DNA methylation-specific prostate cancer screening markers. Dr. Day received his Ph.D. from the University of Missouri in 2001 in Genetics with an emphasis on biochemical genetics of cancer models. His work principally focused on DNA methylation and the effects of different soy phytonutrients on prostate cancer and breast cancer, work which led to several publications. In 1994 and 1996, respectively, Dr. Day earned a Bachelor of Science degree and Master’s of Science degree in Molecular Biology from Brigham Young University. In his free time, Dr. Day is active in his community as an adult leader with Boy Scouts of America and enjoys mentoring the next generation of young people down a path of leadership, education, community service and respect of the outdoors.
Chris
Harmston, MSE
Director of Quality and Applied Technologies
Chris has been with Sorenson Genomics since March 2001 and brings 18 years experience as a quality professional in ISO accredited organizations. Since 2007 Chris has also lead the Sorenson Genomics Information Systems team and the development of internal applications including LIMS based on UNIFlow. Chris' previous work includes the development and management of quality systems in the genomics, manufacturing, construction, and semiconductor industries. Chris' education focused on the semiconductor industry which includes baccalaureate degrees in Physics and Materials Science and a Masters degree in Materials Science and Engineering. With a lifelong passion for rock climbing and mountaineering Chris held the position Quality Manager for Black Diamond Equipment between 1992 and 2000 where the manufacture and testing of climbing equipment became his passion. Chris continues to stay involved in the outdoor industry by volunteering his free time to assist medical researchers understand the physiology of victims buried in snow avalanches.
Donna
J Housley,
Ph.D.
Associate Laboratory Director
Dr. Donna J. Housley is responsible for the review of relationship testing cases including complex family reconstruction cases at Sorenson Genomics. She has provided expert witness testimony in several states. She is involved in educating our existing and prospective clients to aid in the understanding of the genetic testing process and the interpretation of results. She also provides direct assistance to customers to determine which tests are most appropriate for more complex relationship testing such as immigration, social security, and estate cases. Furthermore, Dr. Housley’s research background in human and canine genetics serves as a valuable asset to the Sorenson Genomics' Research and Development team where she contributes to the development, validation, and implementation of new technologies and testing services.
Dr. Housley received a B.S. in Animal Science from the California Polytechnic University at Pomona during which time she developed an interest in laboratory work and genetics. She earned a Ph.D. in Cell and Molecular Biology from the University of Nevada, Reno where her studies focused on the role of heat shock proteins in breast cancer. Dr. Housley’s love of dogs took her to Michigan State University where she began using purebred dogs as a model for studying genetic diseases and other heritable traits, such as behavior. She followed this interest in behavioral genetics to a new lab where she studied genes underlying attention deficit and hyperactivity disorder in people. Her scientific publications focus on the development and use of genetic markers, such as SNPs and SINEs, for use in discovering genes that underlie genetic traits and diseases in both humans and dogs. Dr. Housley joined Identigene in 2010 following two years as an Associate Laboratory Director at Orchid Cellmark in Michigan where she specialized in relationship testing. In her free time, Dr. Housley trains her own dogs and competes in agility competitions nationwide. She is an agility instructor and enjoys teaching people about dog behavior in the hopes of improving the human/animal bond.


